Oncternal Therapeutics
BioTech/Drugs - San Diego, CA, US
Oncternal Therapeutics Employees
Oncternal Therapeutics Senior Management
Oncternal Therapeutics Details
Oncternal Therapeutics is a clinical-stage oncology company developing a diverse pipeline of treatments for cancers with critical unmet medical need. Oncternal focuses drug development on promising yet untapped biological pathways implicated in cancer progression.The pipeline includes cirmtuzumab, a monoclonal antibody in Phase 1/2 development that inhibits the ROR1 receptor in various hematologic cancers; TK-216, a small-molecule in Phase 1 development that inhibits ETS-family oncoproteins, as a treatment for Ewing sarcoma, a rare pediatric cancer; and a CAR-T therapy that targets ROR1 currently in preclinical development as a potential treatment for solid tumors and hematologic cancers.Based in San Diego, Oncternal is committed to advancing its pipeline rapidly and efficiently to bring patients a new wave of first-in-class cancer treatments.
Oncternal Therapeutics Technologies
Email Providers
Outlook
Web Performance Monitoring
New Relic
Tag Management
Google Tag Manager
Fonts
Google Font API
Hosting
Amazon AWS
Search Marketing
Adobe Marketing Cloud